Sandostatin LAR Depot

Indicated For

acromegaly, carcinoid tumors, VIPomas

About This Medication

# Novartis Patient Assistance Foundation Patient Guide: How to Get Sandostatin LAR Depot (octreotide acetate) at Low or No Cost Sandostatin LAR Depot (octreotide acetate) is a long-acting injectable medication used to treat conditions like acromegaly, carcinoid syndrome, and certain neuroendocrine tumors by mimicking somatostatin to reduce hormone secretion.[1][2] The **Novartis Patient Assistance Foundation (NPAF)** offers this drug at low or no cost to eligible patients who meet income guidelines, residency requirements, and have limited insurance coverage.[1][2][3] ## Who Qualifies for the Program? To qualify for free or low-cost **Sandostatin LAR Depot** through NPAF, you must: - Live in the United States or a U.S. territory.[2] - Have a valid prescription from a licensed U.S. healthcare provider for outpatient treatment.[2] - Meet specific income limits, generally up to **400% of the Federal Poverty Level (FPL)**, though this varies by product, household size, and out-of-pocket costs (at least 8% of annual household income for insured patients, except Medicare or uninsured).[program data] - Be uninsured, underinsured, or on government insurance, but not eligible for alternate funding programs.[program data] NPAF reviews applications holistically, prioritizing those with financial hardship. Check eligibility first at www.PAP.Novartis.com.[2][3] ## About Sandostatin LAR Depot **Sandostatin LAR Depot** is an intramuscular depot injection given monthly to control symptoms of hormone-secreting tumors. It helps lower growth hormone in acromegaly patients, reduce diarrhea and flushing in carcinoid syndrome, and manage VIPomas or glucagonomas. Common side effects include gastrointestinal issues, gallstones, and injection-site pain—discuss with your doctor. This program ensures access without high out-of-pocket costs for eligible patients.[1][2] ## Income Eligibility Breakdown Income limits are based on **400% FPL** but adjusted for household size, insurance status, and out-of-pocket expenses. For insured patients (non-Medicare), you may need to spend at least 8% of household income on meds. Use the first two pages of your 1040 tax return as proof; non-filers contact NPAF.[1][2][5] Here's a sample table for 2026 FPL (approximate; verify current at PAP.Novartis.com): | Household Size | 100% FPL | 400% FPL Limit | |---------------|----------|----------------| | 1 | $15,060 | $60,240 | | 2 | $20,440 | $81,760 | | 3 | $25,820 | $103,280 | | 4 | $31,200 | $124,800 | | +1 person | +$5,380 | +$21,520 | *Notes: Limits vary by Sandostatin LAR specifics. Insured households factor in deductibles/co-pays.*[program data][1] ## Insurance Requirements - **Uninsured/underinsured**: Ideal candidates.[program data] - **Government insurance** (e.g., Medicare): Eligible if income-qualified, but provide prior authorization (PA) or appeal denials.[1] - Submit front/back copies of **all** insurance cards (primary, secondary, Rx).[1][2] - Excludes those with alternate funding (e.g., other PAPs).[program data] If insured, prove out-of-pocket burden meets the 8% threshold.[program data] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit www.PAP.Novartis.com for Sandostatin LAR details and income calculator.[2][3][5] 2. **Download Form**: Get the application from PAP.Novartis.com or call (866) 884-5906 / 1-800-277-2254.[program data][4] 3. **Complete Patient Section**: Fill personal info, income (attach 1040 first 2 pages), insurance, residency proof, and sign authorization.[1][2][5] 4. **Doctor Completes HCP Section**: Include prescription, diagnosis, PA/denial if applicable, and sign.[1][4][5] 5. **Gather Documents**: - Proof of income (1040 or contact NPAF if non-filer).[1] - Proof of residency (e.g., utility bill).[program data] - Prescription.[program data][6] - Insurance cards (front/back).[1][2] 6. **Submit**: Fax to 1-855-817-2711 or mail to NPAF, PO Box 2529, Columbus, OH 43216 (or current address).[1][5][8] **Tip**: Incomplete apps delay or deny—double-check![1][2][4] ## Timeline and Delivery - **Processing**: About **4 weeks**; get a letter or text with status/next steps.[3][5] - **Approval**: Medication **shipped directly to you** (or doctor/pharmacy per instructions).[program data] - **Reauthorization**: Required annually or per supply duration—resubmit updated docs.[9][program data] Call 1-800-277-2254 (M-F, 9am-6pm EST) for status.[4] ## Alternatives if Denied - **Appeal**: Contact NPAF for reasons and resubmit missing info.[3][7] - **Other Programs**: Check NeedyMeds, RxAssist, or PAN Foundation for Sandostatin alternatives.[general knowledge] - **Manufacturer Copay Cards**: Novartis may offer for commercially insured (not via NPAF).[general knowledge] - **State Programs**: Medicaid extra help or 340B clinics. - **Biosimilars**: None listed currently.[program data] Visit www.PAP.Novartis.com/faq for more.[7] ## Disclaimer This guide is for informational purposes based on available program data as of 2026. Eligibility, guidelines, and addresses may change—always verify at www.PAP.Novartis.com or call NPAF. Not medical/financial advice; consult your doctor. NPAF not liable for application errors. Word count: ~950.

Program information last verified: March 30, 2026